Old Web
English
Sign In
Acemap
>
authorDetail
>
Michael Cupo
Michael Cupo
GlaxoSmithKline
Virology
Medicine
Rilpivirine
Dolutegravir
Regimen
3
Papers
28
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Driving Automotive Long-Haul Growth
2021
Michael Cupo
Show All
Source
Cite
Save
Citations (0)
319. SWORD 1 and 2: Switch from TDF Containing Regimen to DTG+RPV Maintains Bone Mineral Density and Decreases Bone Turnover Markers Over 148 Weeks
2019
Open Forum Infectious Diseases
Lesley P Kahl
Grace A McComsey
Mónica Coronado Poggio
Sergio H. Lupo
Joss de Wet
David A. Parks
Brian Wynne
Martin Gartland
Kostas Angelis
Alicia Aylott
Michael Cupo
Kati Vandermeulen
Jean van Wyk
K. Smith
Show All
Source
Cite
Save
Citations (0)
Switch from tenofovir disoproxil fumarate combination to dolutegravir plus rilpivirine improves parameters of bone health
2017
AIDS
Grace A. McComsey
Sergio Lupo
David Parks
Mónica Coronado Poggio
Joseph de Wet
Lesley Kahl
Kostas Angelis
Brian Wynne
Kati Vandermeulen
Martin Gartland
Michael Cupo
Michael Aboud
Show All
Source
Cite
Save
Citations (28)
1